[
  {
    "ts": "2025-06-10T12:03:00+00:00",
    "headline": "Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology",
    "summary": "Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a collaboration with The University of Texas MD Anderson Cancer Center (MD Anderson) designed to improve the assessment of elevated risk of cancer in individuals who would benefit from medically appropriate cancer screenings.",
    "url": "https://finance.yahoo.com/news/quest-diagnostics-develop-multi-cancer-120300882.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "54b883e0-a1c3-3878-96b8-f593bab15028",
      "content": {
        "id": "54b883e0-a1c3-3878-96b8-f593bab15028",
        "contentType": "STORY",
        "title": "Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology",
        "description": "",
        "summary": "Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a collaboration with The University of Texas MD Anderson Cancer Center (MD Anderson) designed to improve the assessment of elevated risk of cancer in individuals who would benefit from medically appropriate cancer screenings.",
        "pubDate": "2025-06-10T12:03:00Z",
        "displayTime": "2025-06-10T12:03:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/328ba769d21514205fa2226e0dacf99b",
          "originalWidth": 400,
          "originalHeight": 190,
          "caption": "Quest Diagnostics Incorporated logo. (PRNewsFoto/Quest Diagnostics Incorporated)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FuRCtrLWo1T4qYYDhuscJw--~B/aD0xOTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/328ba769d21514205fa2226e0dacf99b.cf.webp",
              "width": 400,
              "height": 190,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L_XnLitlJHZ7Gn01q1kijg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/328ba769d21514205fa2226e0dacf99b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-develop-multi-cancer-120300882.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-develop-multi-cancer-120300882.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]